California Gov. Jerry Brown signed a law that requires drug price transparency. Photo: Rich Pedroncelli / AP

California Gov. Jerry Brown signed a bill into law Monday that requires pharmaceutical companies to disclose price increases of 16% or more to state officials. Industry groups hate the bill, but consumer groups have hailed the measure as a needed step to address high drug prices.

Point to consider: As the industry has mentioned, California's law does not require insurance companies or pharmacy benefit managers to disclose rebates and discounts they get from drug companies — meaning the prices drug makers disclose could be higher than what many consumers actually pay.

Go deeper

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.

How the coronavirus pandemic could end

Illustration: Sarah Grillo/Axios

It's still the early days of the coronavirus pandemic, but history, biology and the knowledge gained from our first nine months with COVID-19 point to how the pandemic might end.

The big picture: Pandemics don't last forever. But when they end, it usually isn't because a virus disappears or is eliminated. Instead, they can settle into a population, becoming a constant background presence that occasionally flares up in local outbreaks.

Urban housing prices are on the rise

Data: ATTOM Data Solutions; Chart: Naema Ahmed/Axios

Home prices are rising rapidly across the U.S., according to ATTOM Data Solutions.

Driving the news: ATTOM released its 3Q 2020 figures this week, concluding that 77% of metro areas posted "double-digit annual home price gains." Profit margins rose in 86% of the 103 metropolitan statistical areas studied.